The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain
about
Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: A meta-analysis of randomized controlled trials.Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational study.Drug costs in the management of metastatic castration-resistant prostate cancer in Canada.Health resource utilisation associated with skeletal-related events in European patients with lung cancer: Α subgroup analysis from a prospective multinational study.Side effects of bone-targeted therapies in advanced breast cancer.Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational Study.Hospital use among patients with lung cancer complicated by bone metastases and skeletal- related events: a population-based cohort study in Denmark.Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone MetastasisFactors Associated with Life Expectancy in Patients with Metastatic Spine Disease from Adenocarcinoma of the LungBone matters in lung cancer.Bisphosphonates in the Treatment of Patients With Metastatic Breast, Lung, and Prostate Cancer: A Meta-Analysis.Burden of illness of bone metastases in prostate cancer patients in Québec, Canada: A population-based analysis.Incidence and consequences of bone metastases in lung cancer patients.Health resource utilization associated with skeletal-related events in patients with bone metastases: Results from a multinational retrospective - prospective observational study - a cohort from 4 European countriesDisease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists.Hospital visits among women with skeletal-related events secondary to breast cancer and bone metastases: a nationwide population-based cohort study in Denmark.Health resource utilization associated with skeletal-related events: results from a retrospective European studyAge-related differences in persistence with bisphosphonates in women with metastatic breast cancer.Skeletal metastasis: treatments, mouse models, and the Wnt signaling.Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries.Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumoursMicroRNA-93-5p may participate in the formation of morphine tolerance in bone cancer pain mouse model by targeting Smad5.Reducing the burden of bone metastases: current concepts and treatment options.Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases.Clinical, economic and humanistic burdens of skeletal-related events associated with bone metastases.Canadian health care institution resource utilization resulting from skeletal-related events.Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases.Economic evaluation of single-fraction versus multiple-fraction palliative radiotherapy for painful bone metastases in breast, lung and prostate cancer.The Association between Fever and Prognosis in Lung Cancer Patients with Bone Metastases Receiving Zoledronic Acid.The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies - a European survey.Persistence with bisphosphonates in patients with metastatic breast cancer: a retrospective database analysis.Stereotactic radiosurgery versus decompressive surgery followed by postoperative radiotherapy for metastatic spinal cord compression (STEREOCORD): Study protocol of a randomized non-inferiority trial.Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study.Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease.Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study.
P2860
Q33727640-469F6FAB-89D7-4C17-8823-EAC8E986E890Q33887898-2EE86024-7368-4465-AD2B-8BED70F8BA71Q33904772-1D05A27F-A2E7-4476-8E56-64A6C7BCF66EQ33933016-EF2758D2-2122-4ACE-B9BE-A7A85E35B4E1Q35066955-FEE80511-DB9D-4D59-A7A7-C223F67E7BE1Q35667133-A20D4D8D-8B2B-4E1F-8343-50180742F2C9Q35965986-AC76DEE8-690B-4084-94D0-7B6F3D9D79A4Q36068362-FC3E09F7-2258-40A0-A170-A581C8FB2BB2Q36079536-62D431A4-3D0D-4C70-A4B7-788B7A593308Q36182345-A391D5ED-6FDD-4128-8961-5AD61FCE90C1Q36299278-20A8B3EA-1767-479A-96F0-68B21872B9D1Q36326079-369AF040-EDFF-4FBC-A203-8ACB4F48E636Q36491456-BA7A27C3-E9F2-4C08-953B-1B79E4CDA4BAQ36492222-F4D5E1FE-F59E-4DFC-B720-A4AD538038E0Q36558056-C6483748-2170-4FE7-A7DE-43B5EB1F8B62Q36740469-88E3D603-5727-497E-ACBC-B7E43CBAEBB6Q36985287-C4D1C00A-D5AC-42EA-8966-22671AE70518Q37005079-121A672E-2E86-41EC-BDB9-376A23E356C4Q37354085-95C973AA-30D9-43C4-BFBB-9DFA37D41E8AQ37499980-13D57C28-9BBF-41A9-93BF-0AC1BC72E25AQ37583093-DF012D70-5160-400F-A71E-244D0D97D3C5Q37588418-B41D75FA-26EE-4581-B6D4-589C18C15927Q38087306-5566D103-73C0-4D11-890E-EB9D9ED95D13Q38091994-ED43B4C5-894B-407F-BECF-C5BA98DE42B4Q38122189-DC49BA37-641F-48F9-AA20-9F42165FC576Q38190847-99F11416-3F44-4CD9-8381-A4324A78E14EQ38950684-C3D1771E-7C92-41DA-9EA9-BC55887032A4Q39769832-14DA7BDC-B80C-4F10-BF9C-43100847D110Q40052962-51BB1A9C-082E-469B-8EC4-F4B95F1E93A4Q41053000-F04C02E9-DA58-4693-868E-19AEE83BD207Q43604194-802AB61C-2D8F-4E75-B206-5C371477BB33Q47113678-B3F68F18-BAEB-4655-8FD8-A533CF221CE6Q50231606-2DA21D7F-BE1B-4405-BED9-DA955B3E4064Q50853884-9BEA88D5-535E-485C-8E56-7737B3521489Q54941803-945FA31A-E45E-4F04-BC9C-EB43C36A8B5A
P2860
The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The hospital burden of disease ...... r, or prostate cancer in Spain
@ast
The hospital burden of disease ...... r, or prostate cancer in Spain
@en
The hospital burden of disease ...... r, or prostate cancer in Spain
@nl
type
label
The hospital burden of disease ...... r, or prostate cancer in Spain
@ast
The hospital burden of disease ...... r, or prostate cancer in Spain
@en
The hospital burden of disease ...... r, or prostate cancer in Spain
@nl
prefLabel
The hospital burden of disease ...... r, or prostate cancer in Spain
@ast
The hospital burden of disease ...... r, or prostate cancer in Spain
@en
The hospital burden of disease ...... r, or prostate cancer in Spain
@nl
P2093
P2860
P1476
The hospital burden of disease ...... r, or prostate cancer in Spain
@en
P2093
P2860
P304
P356
10.1111/J.1365-2354.2009.01135.X
P407
P577
2010-11-01T00:00:00Z